Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
Price:
1.54 USD
-11.49%
Market Closed
Updated:
May 13, 2024
Cumberland Pharmaceuticals Inc
Pre-Tax Income
|
Cumberland Pharmaceuticals Inc
Pre-Tax Income Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
|
Pre-Tax Income
-$6.3m
|
CAGR 3-Years
1%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-6%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Pre-Tax Income
$20.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
2%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Pre-Tax Income
-$5.8B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Pre-Tax Income
-$1.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Pre-Tax Income
$3.9B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-4%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Pre-Tax Income
$7.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
20%
|
CAGR 10-Years
5%
|
See Also
What is Cumberland Pharmaceuticals Inc's Pre-Tax Income?
Pre-Tax Income
-6.3m
USD
-6.3m
USD
Based on the financial report for Dec 31, 2023, Cumberland Pharmaceuticals Inc's Pre-Tax Income amounts to -6.3m USD.
What is Cumberland Pharmaceuticals Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
-6%
-6%
Over the last year, the Pre-Tax Income growth was -13%. The average annual Pre-Tax Income growth rates for Cumberland Pharmaceuticals Inc have been 1% over the past three years , 10% over the past five years , and -6% over the past ten years .
You don't have any saved screeners yet
